本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Merrimack Pharmaceuticals

15.13
0.0000
成交量:- -
成交额:- -
市值:2.24亿
市盈率:1.08
高:15.13
开:15.13
低:15.13
收:15.13
数据加载中...
2024/05/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2024/05/10

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/30

重要事件披露

Form 8-K - Current report
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/21

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/07

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/03/07

重要事件披露

Form 8-K - Current report
2024/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/08/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/04

重要事件披露

Form 8-K - Current report
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/07

重要事件披露

Form 8-K - Current report